文献速递妇科

1-磷酸鞘氨醇通路在子宫腺肌病中失调

Sphingosine 1-phosphate pathway is dysregulated in adenomyosis.
PubMed 文献 · Reprod Biomed Online · 2022-04-04

本研究从结节型子宫腺肌病患者异位内膜(n=27)与健康对照在位内膜(n=29)的石蜡切片提取RNA,用实时聚合酶链反应检测S1P代谢与信号相关基因及ACTA2表达。结果显示腺肌病样本中SPHK1、SGPP2表达较低,CIB1、S1P3较高、S1P2较低,ACTA2较高且与S1P3相关。作者认为S1P信号轴在子宫腺肌病中严重失调,可能参与纤维化过程。

要点

  • 腺肌病异位内膜SPHK1(P=0.0006)与SGPP2(P=0.0015)表达低于健康对照。
  • 腺肌病样本CIB1表达高于对照(P=0.0001)。
  • 腺肌病样本S1P3表达较高(P=0.001)、S1P2较低(P=0.0019),ACTA2较高(P=0.0001)且与S1P3相关(P=0.0138)。

核心结论

  • 现有数据显示子宫腺肌病中S1P信号轴严重失调,这种生物活性鞘脂可能参与该病的纤维化过程并与ACTA2表达相关,提示其作为子宫腺肌病新型潜在生物标志物的作用。

研究设计与样本

  • 从结节型子宫腺肌病患者异位内膜(n=27)和健康对照女性在位内膜(n=29)的石蜡包埋切片提取RNA。
  • 用实时聚合酶链反应分析S1P代谢与信号相关基因及ACTA2基因编码的α-2平滑肌肌动蛋白表达。

主要发现

  • 腺肌病样本中负责合成S1P的鞘氨醇激酶1(SPHK1)表达较低(P=0.0006)。
  • 腺肌病样本中负责将S1P转化回鞘氨醇的S1P磷酸酶2(SGPP2)表达较低(P=0.0015)。
  • 腺肌病样本中负责SPHK1膜转位的钙与整合素结合蛋白1表达较高(P=0.0001)。
  • 腺肌病样本中S1P受体S1P3 mRNA水平较高(P=0.001),S1P2 mRNA水平较低(P=0.0019)。
  • 腺肌病结节中ACTA2 mRNA水平较高(P=0.0001),且与S1P3水平相关(P=0.0138)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is sphingosine 1-phosphate (S1P) pathway involved in the process of fibrosis in adenomyosis? DESIGN: RNA was extracted from paraffin-embedded slices collected from the ectopic endometrium of patients with nodular adenomyosis (n = 27) and eutopic endometrium of healthy controls women (n = 29). Expression of genes involved in the metabolism and signalling of S1P, and actin-alpha-2 smooth muscle, encoded by ACTA2 gene, a gene involved in fibrogenesis, was evaluated by real-time polymerase chain reaction analysis. RESULTS: In adenomyotic samples, the expression of sphingosine kinase 1 (SPHK1), the enzyme responsible for the synthesis of S1P, and of S1P phosphatase 2 (SGPP2), the enzyme responsible for the conversion of S1P back to sphingosine, was lower (P = 0.0006; P = 0.0015), whereas that of calcium and integrin-binding protein 1, responsible for membrane translocation of SPHK1, was higher (P = 0.0001) compared with healthy controls. In S1P signalling, a higher expression of S1P receptor S1P3 (P = 0.001), and a lower expression of S1P2 (P = 0.0019) mRNA levels, were found compared with healthy endometrium. In adenomyotic nodules, a higher expression of ACTA2 mRNA levels were observed (P = 0.0001), which correlated with S1P3 levels (P = 0.0138). CONCLUSION: Present data show a profound dysregulation of the S1P signalling axis in adenomyosis. This study also highlights that the bioactive sphingolipid might be involved in the fibrotic tract of the disease, correlated with the expression of ACTA2, suggesting its role as novel potential biomarker of adenomyosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Vannuzzi V, Bernacchioni C, Muccilli A, et al. Sphingosine 1-phosphate pathway is dysregulated in adenomyosis. Reprod Biomed Online. 2022. PMID: 35562234. doi:10.1016/j.rbmo.2022.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。